KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) EPS (Weighted Average and Diluted) (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 2.39%
Dec 28, 2025 -1.42%
Sep 28, 2025 -7.42%
Jun 29, 2025 -49.56%
Mar 30, 2025 221.99%
Dec 29, 2024 27.03%
Sep 29, 2024 -42.49%
Jun 30, 2024 44.03%
Mar 31, 2024 -21.18%
Dec 31, 2023 -83.35%
Oct 1, 2023 11,677.35%
Jul 2, 2023 -193.96%
Apr 2, 2023 -102.46%
Jan 1, 2023 -27.38%
Oct 2, 2022 -6.67%
Jul 3, 2022 -6.74%
Oct 3, 2021 -41.70%
Jul 4, 2021 1.29%
Apr 4, 2021 256.92%
Jan 3, 2021 -51.13%
Sep 27, 2020 -2.21%
Jun 28, 2020 -37.33%
Mar 29, 2020 44.67%
Dec 29, 2019 127.27%
Sep 29, 2019 -68.27%
Jun 30, 2019 49.64%
Mar 31, 2019 24.11%
Dec 30, 2018 -22.22%
Sep 30, 2018 -0.69%
Jul 1, 2018 -9.38%
Apr 1, 2018 140.10%
Dec 31, 2017 -391.24%
Oct 1, 2017 -2.14%
Jul 2, 2017 -13.04%
Apr 2, 2017 16.67%
Jan 1, 2017 -9.80%
Oct 2, 2016 6.99%
Jul 3, 2016 -10.06%
Apr 3, 2016 38.26%
Jan 3, 2016 -4.17%
Sep 27, 2015 -25.47%
Jun 28, 2015 5.23%
Mar 29, 2015 71.91%
Dec 28, 2014 -46.39%
Sep 28, 2014 9.93%
Jun 29, 2014 -7.93%
Mar 30, 2014 33.33%
Dec 29, 2013 18.27%
Sep 29, 2013 -21.80%
Jun 30, 2013 9.02%
Mar 31, 2013 34.07%
Dec 30, 2012 -13.33%
Sep 30, 2012 110.00%
Jul 1, 2012 -64.54%
Apr 1, 2012 1,662.50%
Jan 1, 2012 -93.04%
Oct 2, 2011 15.00%
Jul 3, 2011 -20.00%
Apr 3, 2011 78.57%
Jan 2, 2011 -43.09%
Oct 3, 2010 0.00%
Jul 4, 2010 -24.07%
Apr 4, 2010 105.06%
Jan 3, 2010 -34.17%
Sep 27, 2009 4.35%
Jun 28, 2009 -8.73%